Abstract: . . .  Diagnosis of Pulmonary Embolism .................................................... Henri Bounameaux, M.D. 12:35 -12:40 p.m. Discussion 12:40 - 1:10 p.m. Risk Stratification of Pulmonary Embolism .............................. Samuel Z. Goldhaber, M.D. 1:10 - 1:20 p.m. Discussion 1:20 - 2:20 p.m. Lunch 2:20 - 2:50 p.m. Prevention of Venous Thromboembolism Embolism .............................. Samuel Z. Goldhaber, M.D. 2:50 - 3:00 p.m. Discussion Miniupdates 3:00 - 3:15 p.m. Direct Thrombin Inhibitors: Bivalirudin, Lepirudin, Argatroban ...................... David J. Kuter, M.D. 3:15 - 3:20 p.m. Discussion 3:20 - 3:35 p.m. Injectable anti-Xa Agents: . . .
. . .  Director, Center for Outcomes Research, University of Massachusetts Medical School Henri Bounameaux, Associate Professor of Medicine and Director of the Division of Angiology and Hemostasis, University Hospital of Geneva, Geneva, Switzerland Mary Cushman, Associate Professor of Medicine; Hematology/Oncology Unit, Principal Researcher, Laboratory for Clinical Biochemistry Research, University of Vermont College of Medicine, Burlington, Vermont C. Gregory Elliott, Professor, Department of Medicine, Division of Respiratory, Critical Care, and Occupational Pulmonary Medicine, Pulmonary Division, University of Utah Health Sciences Center, LDS Hospital, Salt Lake City, Utah Stavros V. Konstantinides, . . .
. . .  Medicine, George August University of Goettingen, Goettingen, Germany Daniel I. Simon, Herman K. Hellerstein Professor of Medicine; Director, Case Cardiovascular Center, Case School of Medicine; Chief, Division of Cardiology, University Hospitals of Cleveland/Case School of Medicine Jeffrey Weitz, Director of the Experimental Thrombosis and Atherosclerosis (ETA) Programme, Director, Henderson Research Center, Hamilton, Ontario, Canada  . . .
. . .  11:05 -11:20 a.m. Venous Thromboembolism Historical Perspective ................................ Arthur A. Sasahara, M.D. 11:20 -11:25 a.m. Discussion 11:25 -11:55 a.m. Epidemiology of Venous Thromboembolism .......................................................... Mary Cushman, M.D. 11:55 -12:05 p.m. Discussion 12:05 -12:35 p.m. Diagnosis of Pulmonary Embolism .................................................... Henri Bounameaux, M.D. 12:35 -12:40 p.m. Discussion 12:40 - 1:10 p.m. Risk Stratification of Pulmonary Embolism .............................. Samuel Z. Goldhaber, M.D. 1:10 - 1:20 p.m. Discussion 1:20 - 2:20 p.m. Lunch 2:20 - 2:50 p.m. Prevention of . . .
--3000,4,375,3036,16030